Top

Published in:

01-06-2013 | Editorial

Diagnostic criteria of diabetes

Authors: Asako Sato, Yasuhiko Iwamoto

Published in: Diabetology International | Issue 2/2013

Excerpt

The Japan Diabetes Society (JDS) revised diagnostic criteria of diabetes mellitus in 2010 [1]. The major revision was that HbA1c became the first line, that a diagnosis of diabetes was enabled using HbA1c and the plasma glucose level at one time. Early diagnosis and treatment of diabetes are expected by this revision. Prior to it, the American Diabetes Association (ADA) proposed a revision of the diagnostic criteria for diabetes [2]. They also adopted HbA1c in diagnostic criteria to reflect chronic hyperglycemic states better. …

Seino Y, Nanjou K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K. Report of the Committee of Japan Diabetes Society on the Classification and Diagnostic Criteria of Diabetes mellitus. J Jpn Diabetes Soc. 2010;53:450–67 (in Japanese).

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–9.CrossRef

The Committee of Japan Diabetes Society on the Classification and Diagnostic Criteria of Diabetes Mellitus. Report of the Committee of Japan Diabetes Society on the Classification and Diagnostic Criteria of Diabetes mellitus. J Jpn Diabetes Soc. 1999;42:385–404 (in Japanese).

Kosaka K, Akanuma Y, Goto Y, Hakura A, Hirata Y, Kawate R, Kuzuya K, Mimura G, Nakayama H, Sakamoto N, Shigeta Y. Report of the committee on the diagnosis of diabetes mellitus. J Jpn Diabetes Soc. 1982;25:859–66 (in Japanese).

Kuzuya N, Abe M, Ueda H, Kuzuya K, Kuzuya T, Kosaka K, Goto Y, Shigeta Y, Baba S, Hirata Y, Horiuchi A, Yamada K, Wada M. Report of the committee on the diagnostic criteria of the oral glucose tolerance test for diabetes mellitus. J Jpn Diabetes Soc. 1970;13:1–7 (in Japanese).

Kadowaki T, Haneda M, Tominaga M, Yamada N, Iwamoto Y, Tajima N, Noda M, Seino Y, Kashiwaki A, Kuzuya H, Ito C, Nawada H, Yamauchi T. Report of the Japan Diabetes Society’s Committee on the Diagnostic Criteria for Diabetes Mellitus and Glucose Metabolism Disorder—a new category of fasting plasma glucose values: “high-normal”. J Jpn Diabetes Soc. 2008;51:281–3 (in Japanese).

National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57.

WHO Expert Committee on the Diagnosis and Classification on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser 1980;646:1–80.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–97.

10.

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.PubMedCrossRef

11.

Genuth S, Alberti KG, Bennet P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7.PubMedCrossRef

12.

World Health Organization: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. World Health Org 2006

13.

Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H. Importance of OGTT for diagnosis diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract. 2000;49:181–6.PubMedCrossRef

14.

McCance DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 1994;308:1323–8.PubMedCrossRef

15.

Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes; diagnostic criteria and performance revisited. Diabetes Care. 1997;20:785–91.PubMedCrossRef

16.

Colagiuri S, Borch-Johnsen K. DETECT-2: early detection of type 2 diabetes and IGT. Diabetes Voice. 2003;48:11–3.

17.

Ito C, Maeda R, Ishida S, Sasaki H, Harada H. Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract. 2000;50:225–30.PubMedCrossRef

18.

Borch-Johnsen K, Colagiuri S. Diagnosing diabetes-time for change? Diabetologia. 2009;52:2247–50.PubMedCrossRef

19.

Cowie CC, Rusk KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care. 2010;33:562–8.PubMedCrossRef

20.

Shima K, Endo J, Oimomi M, Oshima I, Omori Y, Katayama Y, Kanazawa Y, Kawai T, Kawamori R, Kanno T, Kiyose H, Nakashima K, Nagamine Y, Baba S, Hoshino T, Amino N. Interlaboratory difference in HbA1c measurement in Japan—a report of the committee on an interlaboratory standardization of HbA1c determination, the Japan Diabetes Society. J Jpn Diabetes Soc. 1994;37:855–64 (in Japanese).

21.

Takei I, Okahashi M, Kuwa K, Hishinuma Y, Hoshino T, Tani A, Umemoto M, Miyashita T, Ishibashi M, Tominaga M, Nakayama T, Sanke T, Igarashi M, Koka K, Atsumi Y, Amemiya S, Sugo A, Nagamine Y. JSCC/JDS standard operating procedure for HbA1c measurement. Jpn J Clin Chem. 2009;38:163–76 (in Japanese).

22.

DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef

23.

Bruns DE. Standardization, calibration, the care of diabetic patients. Clin Chem. 1992;38:2363–4.PubMed

24.

ADA, EASD, IFCC, and IDF. Consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabetes care. 2007;30:2399–4000.CrossRef

25.

Kobold U, Jeppsson JO, Dulffer T, Finke A, Hoelzel W, Miedema K. Candidate reference methods for HbA1c based on peptide mapping. Clin Chem. 1997;30:1944–51.

26.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef

27.

The DECODE-study group on behalf of the EDESG. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ. 1998;317:371–5.CrossRef

Title: Diagnostic criteria of diabetes
Authors: Asako Sato
Yasuhiko Iwamoto
Publication date: 01-06-2013
Publisher: Springer Japan
Published in: Diabetology International / Issue 2/2013
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-013-0110-6

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Diagnostic criteria of diabetes

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2013

Correlation between weight loss and improvement of diabetes mellitus among obese type 2 diabetic patients

Report of the JDS/JCA Joint Committee on Diabetes and Cancer

Effects of pravastatin, atorvastatin, and rosuvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia

FSP27 is a potent player regulating lipid storage in liver as well as adipose tissue

Fulminant type 1 diabetes after allogeneic bone marrow transplantation for follicular lymphoma

Mitochondria toxicity of antihyperlipidemic agents bezafibrate and fenofibrate

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page